BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15853681)

  • 1. Targeting neurite growth inhibitors to induce CNS regeneration.
    Kastin AJ; Pan W
    Curr Pharm Des; 2005; 11(10):1247-53. PubMed ID: 15853681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.
    Peterson SL; Nguyen HX; Mendez OA; Anderson AJ
    J Neurosci; 2015 Mar; 35(10):4332-49. PubMed ID: 25762679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble myelin-associated glycoprotein released from damaged white matter inhibits axonal regeneration.
    Tang S; Qiu J; Nikulina E; Filbin MT
    Mol Cell Neurosci; 2001 Sep; 18(3):259-69. PubMed ID: 11591127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Soluble Form of LOTUS inhibits Nogo Receptor-Mediated Signaling by Interfering with the Interaction Between Nogo Receptor Type 1 and p75 Neurotrophin Receptor.
    Kawakami Y; Kurihara Y; Saito Y; Fujita Y; Yamashita T; Takei K
    J Neurosci; 2018 Mar; 38(10):2589-2604. PubMed ID: 29440387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
    Walmsley AR; Mir AK
    Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming inhibitors in myelin to promote axonal regeneration.
    Domeniconi M; Filbin MT
    J Neurol Sci; 2005 Jun; 233(1-2):43-7. PubMed ID: 15949495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal motor neurite outgrowth over glial scar inhibitors is enhanced by coculture with bone marrow stromal cells.
    Wright KT; Uchida K; Bara JJ; Roberts S; El Masri W; Johnson WE
    Spine J; 2014 Aug; 14(8):1722-33. PubMed ID: 24462452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
    Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
    Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD; Schwab ME
    Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho-ROCK inhibitors for the treatment of CNS injury.
    Kubo T; Yamashita T
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):173-9. PubMed ID: 18221230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin-associated glycoprotein in myelin and expressed by Schwann cells inhibits axonal regeneration and branching.
    Shen YJ; DeBellard ME; Salzer JL; Roder J; Filbin MT
    Mol Cell Neurosci; 1998 Sep; 12(1-2):79-91. PubMed ID: 9770342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
    Chen MS; Huber AB; van der Haar ME; Frank M; Schnell L; Spillmann AA; Christ F; Schwab ME
    Nature; 2000 Jan; 403(6768):434-9. PubMed ID: 10667796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter inhibitors in CNS axon regeneration failure.
    Xie F; Zheng B
    Exp Neurol; 2008 Feb; 209(2):302-12. PubMed ID: 17706966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regeneration in the central nervous system.
    Bandtlow CE
    Exp Gerontol; 2003; 38(1-2):79-86. PubMed ID: 12543264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
    Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS.
    Bartsch U; Bandtlow CE; Schnell L; Bartsch S; Spillmann AA; Rubin BP; Hillenbrand R; Montag D; Schwab ME; Schachner M
    Neuron; 1995 Dec; 15(6):1375-81. PubMed ID: 8845160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.